SK Chemical has announced a mid- to long-term business growth strategy aimed at achieving 2.8 trillion won in revenue and 320 billion won in operating profit by 2030. The company also presented a shareholder return policy targeting a total shareholder return ratio of 30% or more from 2026 to 2028.

SK Chemical disclosed these financial targets on the 8th through a public filing of its future business and management plans. The target operating margin for 2030 is 11%, while return on invested capital (ROIC) and return on equity (ROE) are each set at 10+α%. These figures exclude its listed subsidiary SK Bioscience.

By business segment, the company plans to pursue the following: strengthening competitiveness by expanding the high-value Copoly/Monomer portfolio; expanding business and improving profitability based on cost competitiveness in functional materials; turning Recycle operations profitable, building a RaaS (Recycle as a Service) revenue model, and expanding global production bases; and maximizing marketing productivity and expanding into internal medicine areas in Pharma.

The shareholder return policy was also disclosed. SK Chemical set a target of a total shareholder return ratio of 30% or more from 2026 through 2028.

Through the announcement of this mid- to long-term strategy and financial targets, SK Chemical plans to provide key investors with management reference materials and enhance investment visibility, while strengthening the predictability of shareholder returns through its shareholder return policy.

The plan will be presented to domestic and international analysts and institutional investors at the '2026 CEO Investor Day' to be held on the 8th. Related materials will also be posted in the IR section of the company's website.

However, SK Chemical noted that this mid- to long-term strategy and financial targets include forward-looking information, and the contents may change depending on future changes in the business environment or revisions to management plans.